Analysis of Patients Treated With Bevacizumab Intraperitoneal for the Treatment of Refractory Malignant Ascites
CompletedOBSERVATIONAL
Enrollment
30
Participants
Timeline
Start Date
February 28, 2015
Primary Completion Date
May 31, 2015
Study Completion Date
May 31, 2015
Conditions
Refractory Malignant Ascites
Interventions
OTHER
No intervention. Descriptive study
Trial Locations (1)
75014
Groupe Hospitalier Paris Saint Joseph, Paris
All Listed Sponsors
lead
Fondation Hôpital Saint-Joseph
OTHER
NCT02891369 - Analysis of Patients Treated With Bevacizumab Intraperitoneal for the Treatment of Refractory Malignant Ascites | Biotech Hunter | Biotech Hunter